Skip to main content
. 2019 Feb 15;10:54. doi: 10.3389/fphar.2019.00054

Figure 5.

Figure 5

Simvastatin increased Bcl-XL expression in rat liver in LPS-induced inflammation. Distribution of Bcl-XL-positive hepatocytes that were challenged with a non-lethal dose of LPS or either pretreated with simvastatin 40 mg/kg before LPS, magnification 400×. (A) Control group. (B) Note focally distributed BCL-XL-positive hepatocytes in the LPS group, (C) Simvastatin 40 mg/kg + LPS group. Simvastatin increased Bcl-XL expression in rat spleen in LPS-induced inflammation. Distribution of Bcl-XL-positive lymphocytes that were challenged with a non-lethal dose of LPS or either pretreated with simvastatin 40 mg/kg before LPS, magnification 400×. (D) Control group. (E) Note a significant number of BCL-XL-positive lymphocytes in the LPS group, and (F) Simvastatin 40 mg/kg + LPS group.